The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Erwinase 10 000 U powder for solution for injection/infusion



Porton Biopharma LimitedPA23208/001/001

Main Information

Trade NameErwinase 10 000 U powder for solution for injection/infusion
Active SubstancesCrisantaspase
Dosage FormPowder for solution for injection/infusion
Licence HolderPorton Biopharma Limited
Licence NumberPA23208/001/001

Group Information

ATC CodeL01XX02 asparaginase

Status

License statusAuthorised
Licence Issued18/06/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back